Endometriosis (EMs) is a prevalent, estrogen-dependent gynecological disorder characterized by the ectopic implantation and proliferation of endometrial-like tissue outside the uterine cavity, affecting approximately 10% of reproductive-aged women globally. Despite …
Elagolix and Myfembree are gonadotropin-releasing hormone (GnRH)-pathway therapies used for endometriosis, but their post-marketing safety reporting patterns remain incompletely characterized. Because spontaneous reporting databases are susceptible to reporting bias and …
We report an unexpected case of mesonephric-like adenocarcinoma initially treated as a diffuse adenomyosis in a patient presenting with primary infertility. The aim of this report is to raise clinical …
Background/Objectives: This study evaluates the 1-year follow-up outcomes after minimally invasive nerve-sparing surgery for the complete excision of deep endometriosis (DE), with a specific focus on deep dyspareunia. Cases with …
Former paramedic vows to 'fight as hard as I can' after cervical cancer returns as stage four disease SussexWorld
KPTI: Phase III data in myelofibrosis and endometrial cancer signal major advances and rapid adoption TradingView
Blood-based profiling could lead to earlier endometriosis care Contemporary OB/GYN
Endometriosis: The hidden disease behind painful periods PressReader
Marilyn Monroe's Heartbreaking Note To Doctor Amid Secret Health Battle Resurfaces, 'Save Please..' BollywoodShaadis
Rheumatic heart disease (RHD) remains a major cause of cardiovascular morbidity and premature mortality among children and young adults, particularly in low- and middle-income countries. Current management relies on antibiotic …